Tumor mutation burden predicts aggressiveness and prognosis of gastrointestinal stromal tumor
{{output}}
Background: Tumor mutation burden (TMB) has emerged as a promising predictive biomarker for assessing immunotherapy efficacy and clinical outcomes across a wide range of cancer types. We aim to investigate the prognostic value of... ...
